The French Competition Authority delivers its opinion on the distribution of medicinal products and biomedical laboratories

4 April: Distribution of medicinal products and biomedical laboratories: the Autorité delivers its opinion After several months of investigation and a large public consultation, the Autorité de la concurrence releases the findings of its healthcare sector inquiry. The medicinal product distribution sector is undergoing deep transformations. In order to maintain the high level of protection of public health guaranteed in France, by the good network and the quality of the pharmacy network, the Autorité issues proposals. Their goal is to consolidate the pharmacist profession: pharmacists must have strengthened and diversified means to finance the development of their activity, to seize the opportunities offered by the digital technologies, and to be able to develop new missions

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority delivers its opinion on the distribution of medicinal products and biomedical laboratories, 4 April 2019, e-Competitions Bulletin May 2019, Art. N° 90095

Visites 249

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues